Source: International Congress 2014 – Pulmonary hypertension: clinical management
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Paciocco, S. Gamberini, L. Novelli, A. Lucenti, A. Vincenzi, A. Pesci (Monza, Italy). Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD. Eur Respir J 2014; 44: Suppl. 58, 2387

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hemodynamics and lung function in patients with COPD and DPLD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Prognostic value of outcome variables at follow-up in patients with PAH Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Would RDW be a prognostic factor in pulmonary arterial hypertension? Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Characteristics of patients with pulmonary hypertension in end stage renal disease Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Serum apelin 13 levels in patients with pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Lung capillary blood volume and membrane diffusion in PH Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Optimization of PH diagnostic process with IVUS during right heart catheterization Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Female pulmonary arterial hypertension is associated with decreased microRNA96 expression Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Long-term screening for pulmonary hypertension after pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Impact of sepsis in respiratory mechanics of pulmonary arterial hypertension rat model. Preliminary results Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014